vanilmandelic acid has been researched along with Autoimmune Demyelinating Disease, Peripheral in 2 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durocher, A | 1 |
| Servais, B | 1 |
| Caridroix, M | 1 |
| Chopin, C | 1 |
| Wattel, F | 1 |
| Ahmad, J | 1 |
| Kham, AS | 1 |
| Siddiqui, MA | 1 |
2 other studies available for vanilmandelic acid and Autoimmune Demyelinating Disease, Peripheral
| Article | Year |
|---|---|
Autonomic dysfunction in the Guillain-Barré syndrome. Hemodynamic and neurobiochemical studies.
Topics: Adolescent; Adult; Catecholamines; Dysautonomia, Familial; Female; Hemodynamics; Humans; Hydroxyindo | 1980 |
Estimation of plasma and urinary catecholamines in Guillain-Barré syndrome.
Topics: Adolescent; Adult; Humans; Hydrocortisone; Hypertension; Male; Norepinephrine; Polyradiculoneuropath | 1985 |